v3.26.1
Organization and Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Reconciliation of Cash, Cash Equivalents, and Restricted Cash

The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the unaudited condensed consolidated balance sheets that sum to the total of the same such amounts shown in the unaudited condensed consolidated statements of cash flows as of June 30, 2026 and 2025 (in thousands):

 

 

 

As of June 30,

 

 

 

2026

 

 

2025

 

Cash and cash equivalents

 

$

32,429

 

 

$

41,249

 

Restricted cash

 

 

10,050

 

 

 

10,227

 

Total cash, cash equivalents, and restricted cash shown in the unaudited condensed consolidated statement of cash flows

 

$

42,479

 

 

$

51,476

 

Schedule of Basic and Diluted Net Loss per Share Attributable to Stockholders

Basic and diluted net loss per share attributable to stockholders for the three and six months ended June 30, 2026 and 2025 are calculated as follows (in thousands, except share and per share data):

 

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(30,159

)

 

$

(34,070

)

 

$

(61,372

)

 

$

(71,691

)

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Shares used to compute net loss per share, basic and diluted

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding

 

 

116,503,716

 

 

 

114,634,372

 

 

 

116,321,354

 

 

 

114,558,540

 

Weighted-average pre-funded warrants

 

 

3,893,674

 

 

 

3,893,674

 

 

 

3,893,674

 

 

 

3,893,674

 

Weighted-average common shares outstanding used to
    compute basic and diluted net loss per share

 

 

120,397,390

 

 

 

118,528,046

 

 

 

120,215,028

 

 

 

118,452,214

 

Net loss per share, basic and diluted

 

 

 

 

 

 

 

 

 

 

 

 

Basic and diluted

 

$

(0.25

)

 

$

(0.29

)

 

$

(0.51

)

 

$

(0.61

)

Schedule of Anti-Dilutive Securities not Included in Calculation of Net Loss per Common Share

The following weighted-average outstanding shares of potentially dilutive securities are excluded from the computation of diluted net loss per share for the periods presented because including them would have been anti-dilutive:

 

 

 

As of June 30,

 

 

 

2026

 

 

2025

 

Convertible preferred stock

 

 

13,775,430

 

 

 

13,775,430

 

Outstanding options to purchase common stock

 

 

16,350,779

 

 

 

12,694,556

 

Outstanding restricted stock units

 

 

9,000,416

 

 

 

7,047,968

 

Total

 

 

39,126,625

 

 

 

33,517,954